Article Text

Download PDFPDF
Pulmonary disease following intravesical BCG treatment.
  1. S Kesten,
  2. L Title,
  3. B Mullen,
  4. R Grossman
  1. Mount Sinai Hospital, Toronto, Canada.


    Bacillus Calmette-Guérin (BCG) is an attenuated strain of Mycobacterium bovis that has been used in the treatment of malignant disease for over 20 years and for the treatment of bladder cancer since 1976. Major complications of this treatment are infrequent. We report two cases of systemic illness with pulmonary manifestations after treatment with intravesical BCG.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.